Saul – have you an opinion on REGI, with a p/e OF 2.7 and a life sciences division that looks somewhat like Solazyme? Aside from its dependence on subsidies for bio-diesel (and they seem to be going away), it does show a profit from the bio-diesel. At a market cap of $390MM and having a bio division making tailored oils, it might fall into your band of attractive stocks.